N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2— 510(k) K962373

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K962373 for N/T RHEUMATOLOGY CONTROL SL/1 AND SL/2, Substantially Equivalent on 1996-07-11. Applicant: Behring Diagnostics, Inc..

Clearance details

Applicant: Behring Diagnostics, Inc.
Product code: Code DCK
Advisory panel: Immunology
Date received: 1996-06-20
Decision date: 1996-07-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westwood, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.